The Race to Prepare for Medicare’s New Drug Pricing Powers

The Inflation Reduction Act gives Medicare historic new powers to control prescription drug prices. We go inside the government’s race to implement these new powers — and the pharmaceutical industry’s efforts to blunt their impact.


Alice Valder Curran, JD, Partner, Hogan Lovells

Sean Dickson, JD, MPH, Director of Health Policy, West Health Policy Center

Amber Jessup, PhD, Chief Economist, Office of Inspector General, Department of Health and Human Services

Mark Newsom, Founder and Principal, Health Evaluations

Learn more and read a full transcript on our website.

Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.

Support this type of journalism today, with a gift.

Follow us on Twitter

Hosted on Acast. See for more information.